SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-017433 from Guardion Health Sciences, Inc. (GHSI) (CIK 0001642375)

Guardion Health Sciences, Inc. (GHSI) (CIK 0001642375)
Date: May 1, 2024 · CIK: 0001642375 · Accession: 0001493152-24-017433

AI Filing Summary & Sentiment

File numbers found in text: 333-278470

Date
May 1, 2024
Author
Not clearly detected
Form
CORRESP
Company
Guardion Health Sciences, Inc. (GHSI) (CIK 0001642375)

Letter

Guardion Health Sciences, Inc.

Richmond Avenue, Suite 1200

Houston, Texas 77098

May 1, 2024

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Jimmy McNamara

Re: Guardion Health Sciences, Inc.

Registration Statement on Form S-3

File No. 333-278470

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Guardion Health Sciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Friday, May 3, 2024, or as soon thereafter as possible.

Please notify David Sunkin of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (310) 228-2279 or DSunkin@sheppardmullin.com as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

GUARDION HEALTH SCIENCES, INC.

By: /s/ Jan Hall

Name: Jan Hall

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Guardion
Health Sciences, Inc.

2925
Richmond Avenue, Suite 1200

Houston,
Texas 77098

    May
    1, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Jimmy McNamara

    Re:
    Guardion
    Health Sciences, Inc.

    Registration
    Statement on Form S-3

    File
    No. 333-278470

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Guardion Health Sciences, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 4:30 p.m., Eastern Time, on Friday, May 3, 2024, or as soon thereafter as possible.

Please notify David Sunkin of Sheppard, Mullin, Richter & Hampton LLP,
counsel to the Company, at (310) 228-2279 or DSunkin@sheppardmullin.com as soon as possible as to the time the Registration Statement
has been declared effective pursuant to this acceleration request.

    GUARDION
    HEALTH SCIENCES, INC.

    By:
    /s/
    Jan Hall

    Name:
    Jan
    Hall

    Title:
    Chief
    Executive Officer